CFD's zijn complexe instrumenten en gaan gepaard met een hoog risico snel kapitaal te verliezen als gevolg van hefboommechanismen. 74.2% an de retailbeleggers lijdt verlies op de handel in CFD's met deze aanbieder. U dient zorgvuldig te overwegen of u begrijpt hoe CFD's werken en of u het zich kunt veroorloven om hoge risico's te nemen op het verliezen van uw kapitaal.

Close

Handelen Bayer BAYGn

Bayer live grafieken

instrument_fundamentals

Weekly Search
Weekly
Daily
Datum Sluit Verandering % verandering Openen Piek Bodem

Laatste marktnieuws

Tommy Yap 2025 Mar 22, 16:00

Week Ahead: Investor Eyes on U.S. Inflation & Core PCE for Fed’s Next Move

Forex Indices
Frances Wang 2025 Mar 20, 16:00

Stock indices news: US stock indices rose on Fed decision

Indices
Tommy Yap 2025 Mar 20, 16:00

Morning Note: Oil Sanctions, Canada Data, Ripple's Space Gamble

Morning Note Oil Forex
Frances Wang 2025 Mar 19, 16:00

US stock indices update: NASDAQ 100, Dow Jones 30 and S&P 500 Forecast

Indices
Tommy Yap 2025 Mar 19, 16:00

Morning Note: SNB Rate Cut Expected, BoE Decision & Accenture Earnings in Focus

Morning Note Forex
Frances Wang 2025 Mar 18, 16:00

Stock market today: NASDAQ Index, SP500, Dow Jones Forecasts

Stocks
Tommy Yap 2025 Mar 18, 16:00

Morning Note: BoJ Holds Rates, Fed Decision Looms & Tencent Earnings in Focus

Morning Note BoJ Fed
Frances Wang 2025 Mar 17, 16:00

Stock market today: Dow, S&P 500, Nasdaq remain steady on tariff tension

Stocks Indices

Info

Spread

0.15

Spread (%)

0.6242 %

Hefboom

1:5

Dagrente kopen

-0.0556 %

Dagrente verkopen

-0.0333 %

Valuta

EUR

Openingstijden

Markt gesloten

Maandag

08:02 - 11:59

Dinsdag

08:02-11:59

Dinsdag

12:04-16:29

Woensdag

08:02-11:59

Woensdag

12:04-16:29

Donderdag

08:02-11:59

Donderdag

12:04-16:29

Vrijdag

08:02-11:59

Vrijdag

12:04-16:29

instr__analysis_statistics

Openen

---

Vorige Sluiten

---

52-weekse hoog/laag

--- – ---

Beurswaarde

23656769536

Uitstaande aandelen

982424000

Datum winstcijfer (volgende)

2018-06-06

Div. rend.

Ex-dividenddatum

2025-04-28

Jaarlijks verwachte dividendpercentage

0.11

Jaarlijks verwachte dividendrendement

0.0046

Winst per aandeel

-2.6

Meer informatie over dit instrument

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed management as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular, renal, and gynecological diseases; collaboration agreement with Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Gerelateerde instrumenten

Activa
Verkoop
Koop
% verandering
Gerelateerde instrumenten
Trustpilot